Experimental respiratory infection with type 4 adenovirus vaccine in volunteers: clinical and immunological responses.
D000256:Adenoviridae / Q000302:isolation & purification; D000257:Adenoviridae Infections / Q000209:etiology / Q000276:immunology*; D000906:Antibodies / Q000032:analysis; D000917:Antibody Formation; D002214:Capsules; D004064:Digestive System / Q000382:microbiology; D006801:Humans; D007110:Immunity, Active; D008297:Male; D009500:Neutralization Tests; D009666:Nose / Q000382:microbiology; D010614:Pharynx / Q000382:microbiology; D010919:Placebos; D012141:Respiratory Tract Infections / Q000276:immunology*; D012703:Serotyping; D012996:Solutions; D013045:Species Specificity; D014611:Vaccination; D014765:Viral Vaccines / Q000008:administration & dosage* / Q000009:adverse effects
D000906:Antibodies; D002214:Capsules; D010919:Placebos; D012996:Solutions; D014765:Viral Vaccines